Skip to content

Clinical trials

Completed Phase 2 Liposarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liposarcoma Phase: Phase 2 Status: Completed Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20033
20041
20051
20063
20073
20081
20101
20124
20131
20143
20153
20162
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
European Organisation for Research and Treatment of Cancer - EORTC5
Dana-Farber Cancer Institute3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Memorial Sloan Kettering Cancer Center2
Alexander Z. Wei, MD1
Alliance for Clinical Trials in Oncology1
Columbia University1
Daiichi Sankyo1
Grupo Espanol de Investigacion en Sarcomas1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liposarcoma37
Sarcoma27
Leiomyosarcoma21
Fibrosarcoma16
Hemangiosarcoma15
Histiocytoma, Malignant Fibrous15
Sarcoma, Synovial13
Neurofibrosarcoma12
Rhabdomyosarcoma12
Osteosarcoma7

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.